Terms: = Lung cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Clinical Outcome
4 results:
1. Image-guided adaptive radiotherapy in patients with locally advanced non-small cell lung cancer: the art of PET.
Grootjans W; de Geus-Oei LF; Bussink J
Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):369-384. PubMed ID: 29869486
[TBL] [Abstract] [Full Text] [Related]
2. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
Choi M; Kadara H; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Kim K; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Herbst RS; Wistuba II
Ann Oncol; 2017 Jan; 28(1):83-89. PubMed ID: 28177435
[TBL] [Abstract] [Full Text] [Related]
3. Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention.
Al-Wadei HA; Al-Wadei MH; Schuller HM
PLoS One; 2012; 7(1):e29915. PubMed ID: 22253823
[TBL] [Abstract] [Full Text] [Related]
4. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract] [Full Text] [Related]
